Clinical Trial to Evaluate ANT-1403 in the Treatment of Primary Axillary Hyperhidrosis

Inclusion Criteria: * ages 18 - 70 years of age * diagnosis of moderate to severe primary axillary hyperhidrosis * ≥50 mg of sweat production/axilla in 5 minutes as measured gravimetrically * HDSS score of ≥3 Exclusion Criteria: * diagnosis of secondary hyperhidrosis * skin affliction in the axilla requiring medical treatment * 20% aluminum hydrochloride, e.g. Drysol®, in 2 weeks prior of Baseline * oral anticholinergic treatment * botulinum toxin treatment in the prior 9 months * history of surgery for axillary hyperhidrosis * present or history of neuromuscular disease * female subjects who are pregnant or are nursing a child